MorphoSys AG (MOR)
NASDAQ: MOR · IEX Real-Time Price · USD
18.10
-0.06 (-0.33%)
At close: Jul 2, 2024, 4:00 PM
18.04
-0.06 (-0.33%)
After-hours: Jul 2, 2024, 5:14 PM EDT

MorphoSys AG Revenue

In the year 2023, MorphoSys AG had annual revenue of $264.75M, a decrease of -10.56%.

Revenue (ttm)
$264.75M
Revenue Growth
+6.07%
P/S Ratio
10.30
Revenue / Employee
$505,255
Employees
524
Market Cap
2.73B USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023264.75M-31.28M-10.56%
Dec 31, 2022296.03M91.92M45.04%
Dec 31, 2021204.10M-195.53M-48.93%
Dec 31, 2020399.63M319.01M395.67%
Dec 31, 201980.62M-7.24M-8.24%
Dec 31, 201887.86M7.71M9.62%
Dec 31, 201780.15M27.80M53.11%
Dec 31, 201652.35M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 4.78B
Progyny 1.11B
ACADIA Pharmaceuticals 813.81M
Tandem Diabetes Care 770.01M
Azenta 651.76M
Inari Medical 520.66M
TG Therapeutics 289.33M
SpringWorks Therapeutics 26.45M
Revenue Rankings